Markets
Renaissance
@renaissa...
Bought MIRM
Shares
up 6.35%
At 39.0, Now 41.48
Thesis
Go back
Talk
@talkmone...
Bought MIRM
Shares
up 2.32%
At 44.12, Exited 45.15
I'm investing in MIRM because their strong revenue growth of 69% this year, despite expected slower growth next year, shows significant potential. Wit...
Read
More
Thesis
I'm investing in MIRM because their strong revenue growth of 69% this year, despite expected slower growth next year, shows significant potential. With multiple drugs in late-stage trials and a solid cash position to support R&D, Merrim Pharmaceuticals is well-positioned for significant upside.
Go back
